Literature DB >> 22554779

Brief mitochondrial inhibition causes lasting changes in motor behavior and corticostriatal synaptic physiology in the Fischer 344 rat.

G Akopian1, C Crawford, G Petzinger, M W Jakowec, J P Walsh.   

Abstract

The striatum is particularly vulnerable to mitochondrial dysfunction and this problem is linked to pathology created by environmental neurotoxins, stimulants like amphetamine, and metabolic disease and ischemia. We studied the course of recovery following a single systemic injection of the mitochondrial complex II inhibitor 3-nitropropionic acid (3-NP) and found 3-NP caused lasting changes in motor behavior that were associated with altered activity-dependent plasticity at corticostriatal synapses in Fischer 344 rats. The changes in synapse behavior varied with the time after exposure to the 3-NP injection. The earliest time point studied, 24h after 3-NP, revealed 3-NP-induced an exaggeration of D1 Dopamine (DA) receptor dependent long-term potentiation (LTP) that reversed to normal by 48 h post-3-NP exposure. Thereafter, the likelihood and degree of inducing D2 DA receptor dependent long-term depression (LTD) gradually increased, relative to saline controls, peaking at 1 month after the 3-NP exposure. NMDA receptor binding did not change over the same post 3-NP time points. These data indicate even brief exposure to 3-NP can have lasting behavioral effects mediated by changes in the way DA and glutamate synapses interact.
Copyright © 2012 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22554779      PMCID: PMC3371111          DOI: 10.1016/j.neuroscience.2012.04.060

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  77 in total

1.  Modulation of long-term synaptic plasticity at excitatory striatal synapses.

Authors:  F Dos Santos Villar; J P Walsh
Journal:  Neuroscience       Date:  1999-03       Impact factor: 3.590

2.  Abnormal synaptic plasticity in the striatum of mice lacking dopamine D2 receptors.

Authors:  P Calabresi; A Saiardi; A Pisani; J H Baik; D Centonze; N B Mercuri; G Bernardi; E Borrelli
Journal:  J Neurosci       Date:  1997-06-15       Impact factor: 6.167

3.  Aging decreases rebound synaptic excitation produced by removal of NMDA receptor block in the striatum.

Authors:  X Ou; J P Walsh
Journal:  Exp Brain Res       Date:  1997-05       Impact factor: 1.972

4.  Use-dependent exaggeration of brain injury: is glutamate involved?

Authors:  J L Humm; D A Kozlowski; S T Bland; D C James; T Schallert
Journal:  Exp Neurol       Date:  1999-06       Impact factor: 5.330

5.  Mechanisms of cell death induced by the mitochondrial toxin 3-nitropropionic acid: acute excitotoxic necrosis and delayed apoptosis.

Authors:  Z Pang; J W Geddes
Journal:  J Neurosci       Date:  1997-05-01       Impact factor: 6.167

6.  Possible mechanisms in infants for selective basal ganglia damage from asphyxia, kernicterus, or mitochondrial encephalopathies.

Authors:  M V Johnston; A H Hoon
Journal:  J Child Neurol       Date:  2000-09       Impact factor: 1.987

7.  Age-related change in short-term synaptic plasticity intrinsic to excitatory striatal synapses.

Authors:  X Ou; G Buckwalter; T H McNeill; J P Walsh
Journal:  Synapse       Date:  1997-09       Impact factor: 2.562

8.  Increased long-term potentiation in the surround of experimentally induced focal cortical infarction.

Authors:  G Hagemann; C Redecker; T Neumann-Haefelin; H J Freund; O W Witte
Journal:  Ann Neurol       Date:  1998-08       Impact factor: 10.422

9.  Middle cerebral artery occlusion in the rat: consistent protocol for a model of stroke.

Authors:  B S Aspey; S Cohen; Y Patel; M Terruli; M J Harrison
Journal:  Neuropathol Appl Neurobiol       Date:  1998-12       Impact factor: 8.090

10.  Metabolic compromise with systemic 3-nitropropionic acid produces striatal apoptosis in Sprague-Dawley rats but not in BALB/c ByJ mice.

Authors:  T Alexi; P E Hughes; B Knüsel; A J Tobin
Journal:  Exp Neurol       Date:  1998-09       Impact factor: 5.330

View more
  6 in total

Review 1.  Mechanisms for axon maintenance and plasticity in motoneurons: alterations in motoneuron disease.

Authors:  Sibylle Jablonka; Benjamin Dombert; Esther Asan; Michael Sendtner
Journal:  J Anat       Date:  2013-09-06       Impact factor: 2.610

Review 2.  Analysis of Mitochondrial Dysfunction by Microplate Reader in hiPSC-Derived Neuronal Cell Models of Neurodegenerative Disorders.

Authors:  Tatiana R Rosenstock; Congxin Sun; Georgina Wynne Hughes; Katherine Winter; Sovan Sarkar
Journal:  Methods Mol Biol       Date:  2022

3.  Neonatal Rotenone Administration Induces Psychiatric Disorder-Like Behavior and Changes in Mitochondrial Biogenesis and Synaptic Proteins in Adulthood.

Authors:  Amanda Siena; Jéssica Mayumi Camargo Yuzawa; Aline Camargo Ramos; Elisandra Henrique; Mariana Dutra Brito; Mariana Bendlin Calvazara; Tatiana Rosado Rosenstock
Journal:  Mol Neurobiol       Date:  2021-02-19       Impact factor: 5.590

4.  Age-related alterations in the expression of genes and synaptic plasticity associated with nitric oxide signaling in the mouse dorsal striatum.

Authors:  Aisa N Chepkova; Susanne Schönfeld; Olga A Sergeeva
Journal:  Neural Plast       Date:  2015-03-04       Impact factor: 3.599

5.  Ribosomal Protein S6 Phosphorylation Is Involved in Novelty-Induced Locomotion, Synaptic Plasticity and mRNA Translation.

Authors:  Emma Puighermanal; Anne Biever; Vincent Pascoli; Su Melser; Marine Pratlong; Laura Cutando; Stephanie Rialle; Dany Severac; Jihane Boubaker-Vitre; Oded Meyuhas; Giovanni Marsicano; Christian Lüscher; Emmanuel Valjent
Journal:  Front Mol Neurosci       Date:  2017-12-21       Impact factor: 5.639

Review 6.  Metal dyshomeostasis and inflammation in Alzheimer's and Parkinson's diseases: possible impact of environmental exposures.

Authors:  Oddvar Myhre; Hans Utkilen; Nur Duale; Gunnar Brunborg; Tim Hofer
Journal:  Oxid Med Cell Longev       Date:  2013-04-17       Impact factor: 6.543

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.